Device / Technology News

RSS

Oragenics to commence second phase 1 clinical trial for SMaRT Replacement Therapy

Florida-based biopharmaceutical company Oragenics, today announced its intention to commence a second phase 1 clinical trial of SMaRT Replacement Therapy.

31 Jan 2011

Radia announces diagnostic imaging services partnership with Jefferson Healthcare

Radia, is proud to announce a diagnostic imaging services partnership with Jefferson Healthcare commencing on January 1, 2011. Jefferson Healthcare, located in Port Townsend, WA, is a comprehensive healthcare center providing services for the more than 29,500 residents of Jefferson County.

31 Jan 2011

Researchers to develop computer-assisted diagnosis tools for pathologists

Researchers are leveraging Ohio Supercomputer Center resources to develop computer-assisted diagnosis tools that will provide pathologists grading Follicular Lymphoma samples with quicker, more consistently accurate diagnoses.

31 Jan 2011

Revolutions Medical: Major breakthrough in automatic retractable prefilled safety syringe technology

Revolutions Medical Corporation announces a major breakthrough in automatic retractable prefilled safety syringe technology. Building on the Company's proprietary vacuum based technology, important improvements in performance have been made that will set a new gold standard for safety in automatic prefilled syringes.

31 Jan 2011

Physicians suggest new target structure for deep brain stimulation

Nearly ten percent of all cases of depression are so severe that the patients do not respond to any established treatment method. Targeted stimulation of areas in the brain using a type of "brain pacemaker" has recently raised hopes: According to initial studies, half of patients with the most severe depression treated in this manner see a significant improvement in mood.

31 Jan 2011

KCI announces agreement to license Wright Medical Group's GRAFTJACKET for wound care

Kinetic Concepts, announced today an agreement to license Wright Medical Group, GRAFTJACKET brand for use in marketing the LifeCell™ acellular human dermal-based regenerative tissue matrix for wound applications such as diabetic foot ulcers and venous stasis ulcers.

31 Jan 2011

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

Inovio Pharmaceuticals, a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the regulatory approval of a Phase 2 clinical trial to treat leukemia utilizing Inovio's new ELGEN 1000 automated vaccine delivery device.

31 Jan 2011

Sorin Group announces commercial availability of Perceval S aortic heart valve in Europe

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announces the commercial availability in Europe of the self- anchoring Perceval S aortic heart valve. The innovative next-generation valve represents the latest innovation in heart valve technology.

31 Jan 2011

Chrissie Fletcher joins Pharma IQ to discuss about Health Technology Assessment

Chrissie Fletcher joined Pharma IQ to talk about Health Technology Assessment. In this comprehensive podcast, she discussed how she sees health economists and statisticians interacting going forwards, why there is so much emphasis on reporting for reimbursement and whether she expects pharma companies will try and do this more in-house, in the future.

29 Jan 2011

DOJ files civil False Claims Act complaint against Boston Scientific, Guidant

Boston Scientific Corporation today announced that yesterday afternoon, the Civil Division of the U.S. Department of Justice filed a civil False Claims Act complaint against Boston Scientific, Guidant LLC and other entities. This complaint involves Guidant's conduct leading to the 2005 recalls of PRIZM 2 and RENEWAL implantable cardioverter defibrillators.

29 Jan 2011

NexMed presents data on NexACT technology use to improve less permeable, soluable oral drugs

Apricus Biosciences, today announced that its research and development team at its NexMed, USA, Inc. subsidiary is presenting data demonstrating the use of the Company's proprietary NexACT technology to improve less permeable or less soluable drugs, at the Controlled Release Society Product Development Forum for Poorly Soluble Drugs, being held January 27 to 29, 2011, in Miami, Florida.

29 Jan 2011

Published paper suggests some orthodontists may expose young patients to unnecessary radiation

Some orthodontists may be exposing young patients to unnecessary radiation when they order 3-D X-ray imaging for simple orthodontic cases before considering traditional 2-D imaging, suggests a paper published by University of Michigan faculty.

29 Jan 2011

ONR TechSolutions to deliver protective eyewear for warfighters

The Office of Naval Research's TechSolutions department is set to deliver to Navy Special Warfare Command personnel later this year new protective eyewear that will eliminate the need for warfighters to stop to change out colored lenses to accommodate differences in light levels.

29 Jan 2011

Quantros introduces new External Comparative module for hospitals

Quantros, a leading provider of clinically-focused data management and decision support solutions for the healthcare industry, has introduced its new External Comparative module.

29 Jan 2011

Talent Plus offers online solutions to health care organizations for front line selection, development

Talent Plus is pleased to offer Clinical and Non-Clinical Health Care Professional Talent Online Assessments to health care organizations for front line selection and development.

29 Jan 2011

New data shows Shady Grove Fertility financial programs make testing, treatment more affordable

New data shows Shady Grove Fertility Center's financial programs -- designed to help make infertility testing and treatment more affordable -- helped more than a quarter of patients proceed with treatment in 2010, despite the year's significant economic challenges.

29 Jan 2011

GE Capital provides capital to XDx to help increase commercialization of AlloMap molecular diagnostic test

GE Capital, Healthcare Financial Services announced today that it has provided, as sole lender, a $12.5 million senior secured multi-draw term loan facility to XDx, Inc. The financing provides XDx with working capital to expand the commercialization of its FDA-cleared, innovative, noninvasive AlloMap molecular diagnostic test and pursue the development of other gene expression-based tests for autoimmune diseases including lupus.

29 Jan 2011

dbMotion completes interoperability testing at Annual IHE North American Connectathon

dbMotion, a provider of health interoperability solutions, today announced it successfully completed interoperability testing at the 12th Annual IHE North American Connectathon in Chicago.

29 Jan 2011

FWC selects athenahealth's EHR service to provide high-quality care

athenahealth, Inc., a leading provider of web-based practice management, electronic health record, and patient communication services to medical groups, today announced that Florida Woman Care, one of the largest OB/GYN medical groups in Florida, has selected athenahealth's EHR service, athenaClinicals, to provide to its network of 170 physicians a fully scalable, and cost-effective way to share health information, ultimately bringing efficiencies to FWC's workflow and improving its ability to deliver coordinated, high-quality care.

29 Jan 2011

FDA approves Arteriocyte's Magellan MAR01 technology for Phase I trial to treat CLI

Arteriocyte, a leading clinical stage biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts that develops proprietary stem cell and tissue engineering based therapies, announced today approval from the Food and Drug Administration to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb Ischemia.

29 Jan 2011

Device / Technology News

Oragenics to commence second phase 1 clinical trial for SMaRT Replacement Therapy

Radia announces diagnostic imaging services partnership with Jefferson Healthcare

Researchers to develop computer-assisted diagnosis tools for pathologists

Revolutions Medical: Major breakthrough in automatic retractable prefilled safety syringe technology

Physicians suggest new target structure for deep brain stimulation

KCI announces agreement to license Wright Medical Group's GRAFTJACKET for wound care

Inovio announces regulatory approval for Phase 2 trial to treat leukemia using new vaccine delivery device

Sorin Group announces commercial availability of Perceval S aortic heart valve in Europe

Chrissie Fletcher joins Pharma IQ to discuss about Health Technology Assessment

DOJ files civil False Claims Act complaint against Boston Scientific, Guidant

NexMed presents data on NexACT technology use to improve less permeable, soluable oral drugs

Published paper suggests some orthodontists may expose young patients to unnecessary radiation

ONR TechSolutions to deliver protective eyewear for warfighters

Quantros introduces new External Comparative module for hospitals

Talent Plus offers online solutions to health care organizations for front line selection, development

New data shows Shady Grove Fertility financial programs make testing, treatment more affordable

GE Capital provides capital to XDx to help increase commercialization of AlloMap molecular diagnostic test

dbMotion completes interoperability testing at Annual IHE North American Connectathon

FWC selects athenahealth's EHR service to provide high-quality care

FDA approves Arteriocyte's Magellan MAR01 technology for Phase I trial to treat CLI

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News